cyclosporine a plus low-dose steroid treatment in covid-19 improves clinical outcomes in patients with moderate to severe disease .
cyclosporine a plus low-dose steroid treatment in covid-19 improves clinical outcomes in patients with moderate to severe disease .
conclusion: csa used as an adjuvant to steroid treatment for covid-19 patients showed to improve outcomes and reduce mortality, mainly in those with moderate to severe disease.